IL164266A0 - Treatment of gastroparesis - Google Patents

Treatment of gastroparesis

Info

Publication number
IL164266A0
IL164266A0 IL16426603A IL16426603A IL164266A0 IL 164266 A0 IL164266 A0 IL 164266A0 IL 16426603 A IL16426603 A IL 16426603A IL 16426603 A IL16426603 A IL 16426603A IL 164266 A0 IL164266 A0 IL 164266A0
Authority
IL
Israel
Prior art keywords
gastroparesis
treatment
Prior art date
Application number
IL16426603A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL164266A0 publication Critical patent/IL164266A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IL16426603A 2002-04-10 2003-03-27 Treatment of gastroparesis IL164266A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37165002P 2002-04-10 2002-04-10
PCT/US2003/008457 WO2003087139A2 (fr) 2002-04-10 2003-03-27 Traitement de la gastroparesie

Publications (1)

Publication Number Publication Date
IL164266A0 true IL164266A0 (en) 2005-12-18

Family

ID=29250714

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16426603A IL164266A0 (en) 2002-04-10 2003-03-27 Treatment of gastroparesis

Country Status (18)

Country Link
US (1) US20050164925A1 (fr)
EP (1) EP1496924A4 (fr)
JP (1) JP2005530732A (fr)
KR (1) KR20040098063A (fr)
CN (1) CN1735423A (fr)
AU (1) AU2003220403A1 (fr)
BR (1) BR0308904A (fr)
CA (1) CA2480858A1 (fr)
EA (1) EA200401345A1 (fr)
EC (1) ECSP045345A (fr)
HR (1) HRP20040939A2 (fr)
IL (1) IL164266A0 (fr)
MX (1) MXPA04009929A (fr)
NO (1) NO20044815L (fr)
NZ (1) NZ535684A (fr)
PL (1) PL373658A1 (fr)
WO (1) WO2003087139A2 (fr)
ZA (1) ZA200408111B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8666495B2 (en) 1999-03-05 2014-03-04 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
US8792985B2 (en) 2003-07-21 2014-07-29 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
TW200526254A (en) * 2003-09-19 2005-08-16 Novo Nordisk As Novel GLP-1 derivatives
WO2005028516A2 (fr) * 2003-09-19 2005-03-31 Novo Nordisk A/S Nouvelles etiquettes d'affinite pour les proteines plasmiques
ATE532459T1 (de) 2004-08-18 2011-11-15 Metacure Ltd Überwachung, analyse und regulierung von essgewohnheiten
US9339190B2 (en) 2005-02-17 2016-05-17 Metacure Limited Charger with data transfer capabilities
US9821158B2 (en) 2005-02-17 2017-11-21 Metacure Limited Non-immediate effects of therapy
TWI362392B (en) 2005-03-18 2012-04-21 Novo Nordisk As Acylated glp-1 compounds
US8603972B2 (en) 2005-03-18 2013-12-10 Novo Nordisk A/S Extended GLP-1 compounds
WO2006102626A2 (fr) * 2005-03-24 2006-09-28 Metacure Nv Conducteurs sans fil pour applications aux tractus gastro-intestinal
US8463404B2 (en) 2005-03-24 2013-06-11 Metacure Limited Electrode assemblies, tools, and methods for gastric wall implantation
WO2006129321A2 (fr) 2005-06-02 2006-12-07 Metacure N.V. Implantation de fils gi
US8442841B2 (en) * 2005-10-20 2013-05-14 Matacure N.V. Patient selection method for assisting weight loss
US8295932B2 (en) 2005-12-05 2012-10-23 Metacure Limited Ingestible capsule for appetite regulation
AU2012203915B9 (en) * 2006-04-20 2014-10-09 Amgen Inc. GLP-1 compounds
EP2573111A1 (fr) * 2006-04-20 2013-03-27 Amgen Inc. Composés GLP-1
WO2008139463A2 (fr) * 2007-05-09 2008-11-20 Metacure Ltd. Analyse et régulation d'une absorption de nourriture
US8423130B2 (en) * 2008-05-09 2013-04-16 Metacure Limited Optimization of thresholds for eating detection
CN102112157B (zh) 2008-08-06 2013-05-29 诺沃-诺迪斯克保健股份有限公司 具有延长的体内效能的缀合蛋白
CN102292349B (zh) 2009-01-22 2016-04-13 诺沃—诺迪斯克保健股份有限公司 稳定的生长激素化合物
US8841249B2 (en) 2009-08-06 2014-09-23 Novo Nordisk A/S Growth hormones with prolonged in-vivo efficacy
US8642548B2 (en) * 2009-08-07 2014-02-04 Mannkind Corporation Val (8) GLP-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome
US9211342B2 (en) 2010-01-22 2015-12-15 Novo Nordisk Healthcare Ag Stable growth hormone compounds resistant to proteolytic degradation
TWI508737B (zh) 2010-01-22 2015-11-21 諾佛 儂迪克股份有限公司 具有延長的活體內功效的生長激素
WO2011092710A2 (fr) * 2010-02-01 2011-08-04 Metacure Limited Thérapie électrique gastro-intestinale
JP5827218B2 (ja) 2010-04-30 2015-12-02 株式会社三和化学研究所 生理活性物質等の生体内安定性向上のためのペプチド及び生体内安定性が向上した生理活性物質
UA116217C2 (uk) 2012-10-09 2018-02-26 Санофі Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону
BR112015014510A2 (pt) 2012-12-21 2017-11-21 Sanofi Sa agonistas de glp1/gip duais ou de glp1/gip/glucagon trigonais
WO2014166836A1 (fr) 2013-04-05 2014-10-16 Novo Nordisk A/S Formulation de composés d'hormone de croissance

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6268343B1 (en) * 1996-08-30 2001-07-31 Novo Nordisk A/S Derivatives of GLP-1 analogs
JP2002510193A (ja) * 1997-03-31 2002-04-02 イーライ・リリー・アンド・カンパニー グルカゴン様ペプチド−１類似体
IL142707A0 (en) * 2000-04-27 2002-03-10 Pfizer Prod Inc Methods of treating obesity using a neurotensin receptor ligand

Also Published As

Publication number Publication date
EA200401345A1 (ru) 2005-08-25
NZ535684A (en) 2006-03-31
US20050164925A1 (en) 2005-07-28
ECSP045345A (es) 2006-04-19
NO20044815L (no) 2005-01-07
BR0308904A (pt) 2005-05-03
WO2003087139A3 (fr) 2004-01-08
KR20040098063A (ko) 2004-11-18
MXPA04009929A (es) 2006-03-10
WO2003087139A2 (fr) 2003-10-23
PL373658A1 (en) 2005-09-05
CN1735423A (zh) 2006-02-15
JP2005530732A (ja) 2005-10-13
ZA200408111B (en) 2005-10-07
CA2480858A1 (fr) 2003-10-23
EP1496924A2 (fr) 2005-01-19
AU2003220403A1 (en) 2003-10-27
EP1496924A4 (fr) 2007-05-30
HRP20040939A2 (en) 2004-12-31

Similar Documents

Publication Publication Date Title
IL164266A0 (en) Treatment of gastroparesis
GB2393202B (en) Methods of well treatment
IL218909A0 (en) Treatment of diabetes
GB0213869D0 (en) The treatment of pain
GB0211295D0 (en) Treatment of pain
GB0124124D0 (en) Methods of treatment
GB0306309D0 (en) Method of treatment
GB0302572D0 (en) Method of treatment
GB0210741D0 (en) Methods of therapy
AP2004003174A0 (en) Treatment of water
GB0221157D0 (en) Novel treatment
GB0217493D0 (en) Novel methods of treatment
GB0208897D0 (en) New method of treatment
GB0221712D0 (en) Methods of treatment
GB0327975D0 (en) Methods of treatment
GB0213198D0 (en) Method of treatment
GB0207091D0 (en) Method of treatment
GB0208783D0 (en) Methods of treatment
GB0223254D0 (en) Methods of treatment
GB0329357D0 (en) Treatment of materials
AU2003276123A8 (en) Treatment of uveal melanoma
GB0215583D0 (en) Method of treatment
GB0206699D0 (en) Method of treatment
GB0221582D0 (en) Method of treatment
GB0201281D0 (en) Method of treatment